There are many challenges in adopting and maintaining a gluten-free diet that can impact a person’s quality of life and long-term health outcomes. Patients, doctors and researchers agree that there is a great need for alternative treatments that could replace or supplement the gluten-free diet.
This section will share information and updates about the drug discovery and development processes. Learn about the latest from pharmaceutical and biotech companies, as well as how you can get involved in clinical trials that will advance celiac disease research.
Sign Up to Receive Research News and Announcements
Research in the area of celiac disease and other gluten-related disorders advances every day. From online surveys to clinical trials, there are many opportunities to get involved and help researchers move closer to increased diagnoses, improved disease management tools, new pharmaceutical treatments and even a cure for celiac disease. Patient participation in research is key to ensuring that the field continues to advance. Sign up for the Beyond Celiac Research Opt-In today to learn more about opportunities to participate in research.
|Sign up: Beyond Celiac Research News|
Find the latest information about celiac disease drugs being studied, how they would work and how far they are in the clinical trial process with our drug pipeline.
Researchers around the world are working to develop new treatments for celiac disease beyond the gluten-free diet. As a person affected by celiac disease, you can play an important role in advancing research by participating in a clinical trial or study.
Read the latest in research into celiac disease and gluten-related disorders.
Beyond Celiac has a bold plan for a better future. Having revised its vision and mission in Spring of 2017, the organization announced its plan and has set its sights on conquering the disease all together.
In 2019, Beyond Celiac launched our strategic science plan to create pathways to treatments and cure for celiac disease. Our mission has evolved to one of advancing the science of celiac disease because we firmly believe that with a strategic approach to funding focused research, an effective treatment or cure could be possible by 2030. To accomplish that goal, we are laser-focused and addressing the many barriers currently existing.